7536
P. Bisegger et al. / Tetrahedron 64 (2008) 7531–7536
The analogous cleavage of resin 11 (0.51 mmol) obtained by the
Mitsunobu cyclization delivered compound 12 (54 mg, 0.18 mmol)
with an overall yield of 35.5%.
26.3 (t, 2C). CI-MS: 345 (95, [MþH]þ), 315 (78), 281 (100,
[MþHꢀSO2]þ).
4.4.4.2. Data of 27. IR: 2974m, 2359m, 1683s, 1604m, 1507m,
1333s, 1201m, 1138m, 1053w, 1033w, 910w, 832w, 720w. 1H NMR
(MeOH-d4): 8.57 (d, 4J¼2.8, 1 arom. H), 8.29 (dd, 3,4J¼9.5, 2.8, 1
arom. H), 7.42 (d, 3J¼9.5, 1 arom. H), 3.58 (t, 3J¼6.1, 4H), 3.36–3.30
(m, 4H), 2.24–2.16 (m, 4H). 13C NMR (MeOH-d4): 149.6 (s, 1C), 139.7,
139.4 (2s, 2CNO2), 128.9, 124.3, 119.9 (3d, 3 arom. C), 51.8 (t, 2C),
44.8 (t, 2C), 24.6 (t, 2C). CI-MS: 281 (100, [MþH]þ), 251 (12).
4.4.2. 1-[(2-Nitrobenzene)sulfonyl]-1,5,9-triazacyclodo-decane (15)
Analogous to Section 4.4.1, resin 13 (0.58 mmol) delivered after
purification by chromatography (CH2Cl2/MeOH/NH3 (25% in H2O)
9:1.5:0.2) 15 as the free base (62 mg, 0.17 mmol; overall yield 30%
with respect to 2). IR: 3350w, 2980m, 2880m, 1565s, 1500w, 1400s,
1370s, 1190s, 1160m, 945w, 885w. 1H NMR (CDCl3): 8.04–7.97 (m, 1
arom. H), 7.74–7.56 (m, 3 arom. H), 3.49 (t, 3J¼7.0, 4H), 2.83–2.75
(m, 4H), 2.73–2.64 (m, 4H), 2.16 (br s, 2NH), 1.78–1.65 (m, 4H), 1.55
(quint., 3J¼5.4, 2H). 13C NMR (CDCl3): 148.4 (s, CNO2), 133.6 (s,
CSO2), 133.5, 131.7, 130.8, 124.2 (4d, 4 arom. C), 45.8 (t, 2C), 45.4 (t,
2C), 44.2 (t, 2C), 28.8 (t), 26.1 (t, 2C). CI-MS: 357 (100, [MþH]þ).
The analogous cleavage of resin 13 (0.51 mmol) obtained by the
Mitsunobu cyclization delivered compound 15 (62 mg, 0.17 mmol)
with an overall yield of 34.0%.
4.4.4.3. Data of 28. Mp: 131.1–133.6 ꢁC (yellow solid after lyophy-
lization). IR (KBr): 3329m, 3097m, 3045m, 2842m, 1662s, 1624s,
1586s, 1526s, 1474m, 1422s, 1352s, 1318m, 1281s, 1270s, 1196s,
1171s, 1040s, 1104m, 1055w, 1022w, 921w, 833m, 826m, 803m,
780w, 768w, 745m, 721s, 689w, 660w. 1H NMR (MeOH-d4): 9.05 (d,
4J¼2.7,1 arom. H), 8.32 (dd, 3,4J¼9.6, 2.7,1 arom. H), 7.21 (d, 3J¼9.6,1
arom. H), 3.71–3.61 (m, 4H), 3.32–3.14 (m, 4H), 2.19–2.08 (m, 4H).
13C NMR (MeOH-d4): 149.5 (s, CSO2), 137.4 (s, CNO2), 132.2 (s,
CNO2), 131.2, 124.8, 115.6 (3d, 3 arom. C), 46.6 (t, 2C), 42.1 (t, 2C),
41.0 (t, 2C), 30.2 (t, 2C), 26.6 (t, 2C). CI-MS: 317 (25, [MþH]þ), 281
(25, [MþHꢀHCl]þ), 251 (18).
4.4.3. 1-[(2-Nitrobenzene)sulfonyl]-1,5,9,13-tetraazacyclo-
hexadecane (16)
Analogous to Section 4.4.1, resin 14 (0.87 mmol) delivered
compound 16 as the free base (109 mg, 0.26 mmol; overall yield
30% with respect to 2) after rinsing the crude mixture with CH2Cl2
and purifying the rest by chromatography (CH2Cl2/MeOH/NH3 (25%
in H2O), with the following gradient 10:2:0.1/4:1:0.1/7:3:1). IR:
3290m, 2940s, 1550s, 1470m, 1375s, 1345s, 1165s, 1130m, 1020w,
855w. 1H NMR (MeOH-d4): 8.14–8.06 (m, 1 arom. H), 7.94–7.80 (m,
3 arom. H), 3.48 (t, 3J¼7.4, 4H), 2.84–2.69 (m, 12H), 1.94–1.70 (m,
8H). 13C NMR (MeOH-d4): 149.9 (s, CNO2), 135.3 (d, 1 arom. C), 133.9
(s, CSO2), 133.2, 131.4, 125.5 (3d, 3 arom. C), 49.4 (t, 2C), 48.9 (t, 2C),
47.9 (t, 2C), 47.0 (t, 2C), 29.4 (t, 2C), 29.3 (t, 2C). CI-MS: 414 (100,
[MþH]þ), 396 (29), 384 (92), 350 (22).
Acknowledgements
We like to thank the Swiss National Science Foundation for their
generous financial support.
References and notes
1. Caravan, P.; Ellison, J. J.; McMurry, J.; Lauffer, R. B. Chem. Rev. 1999, 99, 2293–
2352.
2. Anderson, C. J.; Welch, M. J. Chem. Rev. 1999, 99, 2219–2234.
3. Guo, Z.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 1512–1531.
4. Reichenbach-Klinke, R.; Koenig, B. J. Chem. Soc., Dalton Trans. 2002, 121–130.
5. Itoh, T.; Takagi, Y.; Maurakami, T.; Hiyama, Y.; Tsukube, H. J. Org. Chem. 1996, 61,
2158–2163.
The analogous cleavage of resin 14 (0.51 mmol) obtained by the
Mitsunobu cyclization delivered compound 16 (54 mg, 0.13 mmol)
with an overall yield of 25.4%.
6. Bridger, G. J.; Skerlj, R. T.; Thornton, D.; Padmanabhan, S.; Martellucci, S. A.;
Henson, G. W.; Abrams, M. J.; Yamamoto, N.; De Vreese, K.; Pauwels, R.;
De Clercq, E. J. Med. Chem. 1995, 38, 366–378.
7. Le Baccon, M.; Chuburu, F.; Toupet, L.; Handel, H.; Soibinet, M.; De´champs-
Olivier, I.; Barbier, J.-P.; Aplincourt, M. New J. Chem. 2001, 25, 1168–1174.
8. Manov, N.; Bienz, S. Tetrahedron 2001, 57, 7893–7898.
9. Manov, N.; Tzouros, M.; Chesnov, S.; Bigler, L.; Bienz, S. Helv. Chim. Acta 2002,
85, 2827–2846.
10. Manov, N.; Tzouros, M.; Bigler, L.; Bienz, S. Tetrahedron 2004, 60, 2387–2391.
11. Hidai, Y.; Kan, T.; Fukuyama, T. Chem. Pharm. Bull. 2000, 48, 1570–1576.
12. Anderson, T. F.; Strømgaard, K. Tetrahedron Lett. 2004, 45, 7929–7933.
13. Conti, P.; Demont, D.; Cals, J.; Ottenheijm, H. C. J.; Leysen, D. Tetrahedron Lett.
1997, 38, 2915–2918.
14. Kung, P.; Swayze, E. Tetrahedron Lett. 1999, 40, 5651–5654.
15. Hone, N. D.; Payne, L. J. Tetrahedron Lett. 2000, 41, 6149–6152.
16. Fukuyama, T.; Cheung, M.; Jow, C.-K.; Hidai, Y.; Kan, T. Tetrahedron Lett. 1997, 38,
5831–5834.
4.4.4. 1-[(2,4-Dinitrobenzene)sulfonyl]-1,5-diazacyclo-octane (26),
1-(2,4-dinitrobenzene)-1,5-diazacyclo-octane (27), and N-(3-
chloropropyl)-N0-(2,4-dinitrophenyl)-propane-1,3-diamine (28)
Resin 25 (0.59 mmol) was swelled in 1,2-dichloroethane (10 ml)
and 1-chloroethyl chloroformate (0.65 ml, 5.85 mmol) was added.
After agitation for 3 h at 23 ꢁC under Ar, the product resin was fil-
tered off and washed with CH2Cl2. The organic solutions were
combined and evaporated to dryness. The residue was dissolved in
MeOH, and the resulting solution was refluxed for 3 h. The solvent
was removed, and the residue was purified by HPLC (RP C-18;
solvent (MeCN/H2O/TFA 25:74.95:0.05)) to give pure 26 as the TFA
salt (15.6 mg, 0.034 mmol; overall yield 5.8% with respect to 21),
the Smiles product 27 (14.6 mg, 0.037 mmol; overall yield 6.2% with
respect to 21), and the non-cyclic compound 28 (15.1 mg,
0.035 mmol; overall yield 6.0% with respect to 21).
17. Bisegger, P. University of Zurich 2007, unpublished results.
18. Lorand, L.; Parameswaran, K. N.; Stenberg, P.; Tong, Y. S.; Velasco, P. T.; Jo¨nsson,
N. A.; Mikiver, L.; Moses, P. Biochemistry 1979, 18, 1756–1765.
19. Renault, J.; Lebranchu, M.; Lecat, A.; Uriac, P. Tetrahedron Lett. 2001, 42,
6655–6658.
4.4.4.1. Data of 26. IR (KBr): 3434m, 3102m, 3034m, 2990m,
2972m, 2926m, 2875m, 2820m, 2762m, 2565m, 2474w, 1676s,
1621s, 1606m, 1563s, 1540s, 1472m, 1464m, 1430m, 1371s, 1356s,
1197s, 1176s, 1162s, 1144m, 1020s, 1051w, 1034m, 1007m, 970w,
904m, 851w, 835m, 824w, 798m, 751s, 721m, 696m, 658w. 1H NMR
(MeOH-d4): 8.75 (s, 1 arom. H), 8.61 (d, 3J¼8.8, 1 arom. H), 8.29 (d,
3J¼8.6, 1 arom. H), 3.58–3.54 (m, 4H), 3.39–3.36 (m, 4H), 2.18–2.16
(m, 4H). 13C NMR (MeOH-d4): 151.8, 150.0 (2s, 2CNO2), 137.2 (s,
CSO2), 133.4, 127.7, 121.3 (3d, 3 arom. C), 48.6 (t, 2C), 44.9 (t, 2C),
20. Illuminati, G.; Mandolini, L. Acc. Chem. Res. 1981, 14, 95–102.
21. Allinger, N. M.; Zalkow, V. J. Org. Chem. 1960, 25, 701–704.
22. Kirby, A. J. Adv. Phys. Org. Chem. 1980, 17, 208–222.
23. DeTar, D. F.; Luthra, N. P. J. Am. Chem. Soc. 1980, 102, 4505–4512.
24. Jager, J.; Graafland, T.; Schenck, H.; Kirby, A. J.; Engberts, J. B. F. N. J. Am. Chem.
Soc. 1984, 106, 139–143.
25. Sternbach, D. D.; Rossana, D. M.; Onan, K. D. Tetrahedron Lett. 1985, 26, 591–594.
26. Beesley, R. M.; Ingold, C. K.; Thorpe, J. F. J. Chem. Soc. 1915, 107, 1080–1106.
27. Ngu, K.; Patel, D. V. Tetrahedron Lett. 1997, 38, 973–976.
28. Lu, G.-s.; Mojsov, S.; Tam, J. P.; Merrifield, R. B. J. Org. Chem. 1981, 46,
3433–3436.